Mechanism of Huanglian Jiedu Decoction in treatment of type 2 diabetes mellitus based on intestinal flora.
10.19540/j.cnki.cjcmm.20240730.403
- Author:
Xue HAN
1
;
Qiu-Mei TANG
2
;
Wei WANG
2
;
Guang-Yong YANG
2
;
Wei-Yi TIAN
2
;
Wen-Jia WANG
2
;
Ping WANG
2
;
Xiao-Hua TU
2
;
Guang-Zhi HE
2
Author Information
1. Guizhou University of Traditional Chinese Medicine Guiyang 550025, China Department of Gastroenterology and Endocrinology, Dejiang County People's Hospital Tongren 554300, China.
2. Guizhou University of Traditional Chinese Medicine Guiyang 550025, China.
- Publication Type:Journal Article
- Keywords:
16S rRNA;
Huanglian Jiedu Decoction;
intestinal flora;
type 2 diabetes mellitus
- MeSH:
Animals;
Drugs, Chinese Herbal/administration & dosage*;
Diabetes Mellitus, Type 2/metabolism*;
Gastrointestinal Microbiome/drug effects*;
Rats;
Male;
Rats, Sprague-Dawley;
Humans;
Bacteria/drug effects*;
Blood Glucose/metabolism*
- From:
China Journal of Chinese Materia Medica
2025;50(1):197-208
- CountryChina
- Language:Chinese
-
Abstract:
The effect of Huanglian Jiedu Decoction on the intestinal flora of type 2 diabetes mellitus(T2DM) was investigated using 16S rRNA sequencing technology. Sixty rats were randomly divided into a normal group(10 rats) and a modeling group(50 rats). After one week of adaptive feeding, a high-fat diet + streptozotocin was given for modeling, and fasting blood glucose >16.7 mmol·L~(-1) was considered a sign of successful modeling. The modeling group was randomly divided into the model group, high-, medium-, and low-dose groups of Huanglian Jiedu Decoction, and metformin group. After seven days of intragastric treatment, the feces, colon, and pancreatic tissue of each group of rats were collected, and the pathological changes of the colon and pancreatic tissue of each group were observed by hematoxylin-eosin staining. The changes in the intestinal flora structure of each group were observed by the 16S rRNA sequencing method. The results showed that compared with the model group, the high-, medium-, and low-dose of Huanglian Jiedu Decoction reduced fasting blood glucose levels to different degrees and showed no significant changes in body weight. The number of islet cells increased, and intestinal mucosal damage attenuated. Alpha diversity analysis revealed that Huanglian Jiedu Decoction reduced the abundance and diversity of intestinal flora in rats with T2DM; at the phylum level, low-and mediam-dose of Huanglian Jiedu Decoction reduced the abundance of Bacteroidota, Proteobacteria, and Desulfobacterota and increased the abundance of Firmicute and Bacteroidota/Firmicutes, while the high-dose of Huanglian Jiedu Decoction increased the relative abundance of Proteobacteria and Bacteroidota/Firmicutes ratio, and decreaseal the relative; abundance of Firmicute; at the genus level, Huanglian Jiedu Decoction increased the relative abundance of Allobaculum, Blautia, and Lactobacillus; LEfse analysis revealed that the biomarker of low-and medium-dose groups of Huanglian Jiedu Decoction was Lactobacillus, and the structure of the intestinal flora of the low-dose group of Huanglian Jiedu Decoction was highly similar to that of the metformin group. PICRUSt2 function prediction revealed that Huanglian Jiedu Decoction mainly affected carbohydrate and amino acid metabolic pathways. It suggested that Huanglian Jiedu Decoction could reduce fasting blood glucose and increase the number of islet cells in rats with T2DM, and its mechanism of action may be related to increasing the abundance of short-chain fatty acid-producing strains and Lactobacillus and affecting carbohydrate and amino acid metabolic pathways.
